HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
sporamycin
isolated from culture filtrate of Streptopsorangium strain PO-357
Also Known As:
PO-357
Networked:
7
relevant articles (
3
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Peptides: 82426
sporamycin: 7
Related Diseases
1.
Neoplasms (Cancer)
08/01/1981 - "
Sporamycin inhibited the growth of the Meth-A tumor and Balb/c mice, and 12 out of 19 mice were cured.
"
08/01/1981 - "
A marked neutralization activity against tumor cells was observed by Winn's method using spleen cell of tumor-bearing mice which had been pre- or post-treated with sporamycin.
"
08/01/1981 - "
Pretreatment of mice with sporamycin produced a remarkable inhibition of tumor growth.
"
08/01/1981 - "
The role of immunological effects in the antitumor activity of sporamycin activity of sporamycin was studied mainly using the mouse syngeneic tumor, Meth-A.
"
01/01/1980 - "
The results suggest that enhancement both of antigenicity of the tumor (cells) and of the subsequent immune response of the host by sporamycin may be involved in the cure of the experimental tumor.
"
2.
Ascites
04/01/1979 - "
Sporamycin did not affect DNA synthesis in vitro catalyzed by partially purified DNA polymerase alpha, beta, and gamma derived from EHRLICH ascites cells.
"
04/01/1977 - "
After nine daily doses of the antibiotic had been given to dd mice bearing Ehrlich ascites carcinoma, significant increase of lifespan was observed at doses of 5.0 approximately 1.3 mg/kg. A marked decrease in tumor size of sarcoma-180 transplanted subcutaneously was observed when the mice were treated by daily or single injection of Sporamycin.
"
3.
Carcinoma (Carcinomatosis)
04/01/1977 - "
After nine daily doses of the antibiotic had been given to dd mice bearing Ehrlich ascites carcinoma, significant increase of lifespan was observed at doses of 5.0 approximately 1.3 mg/kg. A marked decrease in tumor size of sarcoma-180 transplanted subcutaneously was observed when the mice were treated by daily or single injection of Sporamycin.
"
4.
Infections
12/01/1984 - "
Pretreatment of mice with sporamycin produced not only a remarkable inhibition of tumor growth but also strengthened the resistance of the host to infection with Pseudomonas aeruginosa.
"
5.
Delayed Hypersensitivity (Hypersensitivity, Type IV)
11/01/1979 - "
(2) The delayed hypersensitivity tested by the foot-pad reaction was positive in tumor-bearing mice treated with sporamycin, and no decrease of foot pad reaction was observed, whereas this reaction decreased remarkably in non-treated tumor-bearing mice.
"
Related Drugs and Biologics
1.
Anti-Bacterial Agents (Antibiotics)
2.
Peptides (Polypeptides)
3.
DNA Polymerase I (Klenow Fragment)
4.
DNA (Deoxyribonucleic Acid)
5.
Antigens
Related Therapies and Procedures
1.
Transplantation
2.
Intravenous Administration